HUE051592T2 - Kezelési módszer - Google Patents

Kezelési módszer

Info

Publication number
HUE051592T2
HUE051592T2 HUE14711232A HUE14711232A HUE051592T2 HU E051592 T2 HUE051592 T2 HU E051592T2 HU E14711232 A HUE14711232 A HU E14711232A HU E14711232 A HUE14711232 A HU E14711232A HU E051592 T2 HUE051592 T2 HU E051592T2
Authority
HU
Hungary
Prior art keywords
treatment
Prior art date
Application number
HUE14711232A
Other languages
English (en)
Inventor
Yaela Baine
Jacqueline Miller
Original Assignee
Glaxosmithkline Biologicals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa
Publication of HUE051592T2 publication Critical patent/HUE051592T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Virology (AREA)
HUE14711232A 2013-03-18 2014-03-17 Kezelési módszer HUE051592T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361802918P 2013-03-18 2013-03-18
US201361874008P 2013-09-05 2013-09-05

Publications (1)

Publication Number Publication Date
HUE051592T2 true HUE051592T2 (hu) 2021-03-01

Family

ID=50336313

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14711232A HUE051592T2 (hu) 2013-03-18 2014-03-17 Kezelési módszer

Country Status (21)

Country Link
US (1) US11883478B2 (hu)
EP (1) EP2976101B1 (hu)
JP (2) JP6747968B2 (hu)
KR (1) KR20150121265A (hu)
CN (1) CN105188743A (hu)
AU (1) AU2014234408B2 (hu)
BE (1) BE1021934B1 (hu)
BR (1) BR112015024014A2 (hu)
CA (1) CA2903322C (hu)
CY (1) CY1123600T1 (hu)
DK (1) DK2976101T3 (hu)
EA (1) EA034380B1 (hu)
ES (1) ES2830035T3 (hu)
HU (1) HUE051592T2 (hu)
IL (1) IL241096B (hu)
MX (1) MX2015013401A (hu)
PL (1) PL2976101T3 (hu)
PT (1) PT2976101T (hu)
SG (2) SG10201710137QA (hu)
SI (1) SI2976101T1 (hu)
WO (1) WO2014147044A1 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI3506935T3 (fi) * 2016-09-02 2024-04-17 Sanofi Pasteur Inc Neisseria meningitidis -rokote
CN111542339B (zh) * 2017-11-06 2024-06-04 Ozq私人有限公司 疫苗
CN110652585B (zh) * 2018-10-26 2023-05-26 武汉博沃生物科技有限公司 多糖-蛋白缀合物免疫制剂及其制备与应用
MX2022006054A (es) * 2019-11-22 2022-06-24 Glaxosmithkline Biologicals Sa Dosificacion y administracion de una vacuna de glucoconjugados de sacaridos bacterianos.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7018637B2 (en) 1998-02-23 2006-03-28 Aventis Pasteur, Inc Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
SI21352A (sl) * 2001-01-23 2004-06-30 Aventis Pasteur Multivalentno meningokokno cepivo iz konjugata polisaharida-proteina
GB0409745D0 (en) * 2004-04-30 2004-06-09 Chiron Srl Compositions including unconjugated carrier proteins
KR20130122810A (ko) * 2005-06-27 2013-11-08 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신 제조 방법
AU2012203419B2 (en) * 2005-06-27 2014-06-26 Glaxosmithkline Biologicals S.A. Immunogenic composition
AU2006327023A1 (en) * 2005-12-23 2007-06-28 Glaxosmithkline Biologicals Sa Conjugate vaccines
PL2004225T3 (pl) 2006-03-22 2012-09-28 Novartis Ag Schematy immunizacji koniugatami meningokokowymi

Also Published As

Publication number Publication date
KR20150121265A (ko) 2015-10-28
PL2976101T3 (pl) 2021-03-08
EA034380B1 (ru) 2020-01-31
CA2903322C (en) 2023-09-05
EP2976101A1 (en) 2016-01-27
JP2016515539A (ja) 2016-05-30
IL241096B (en) 2021-05-31
ES2830035T3 (es) 2021-06-02
DK2976101T3 (da) 2020-11-23
SG11201506810RA (en) 2015-10-29
BR112015024014A2 (pt) 2017-07-18
CA2903322A1 (en) 2014-09-25
JP2019142898A (ja) 2019-08-29
PT2976101T (pt) 2020-11-12
US20160279225A1 (en) 2016-09-29
CN105188743A (zh) 2015-12-23
BE1021934B1 (fr) 2016-01-27
AU2014234408A1 (en) 2015-10-22
US11883478B2 (en) 2024-01-30
MX2015013401A (es) 2016-01-08
AU2014234408B2 (en) 2017-04-20
SG10201710137QA (en) 2018-01-30
WO2014147044A1 (en) 2014-09-25
JP6747968B2 (ja) 2020-08-26
EP2976101B1 (en) 2020-08-19
SI2976101T1 (sl) 2021-01-29
CY1123600T1 (el) 2022-03-24
IL241096A0 (en) 2015-11-30
EA201591468A1 (ru) 2016-04-29

Similar Documents

Publication Publication Date Title
HK1217908A1 (zh) 治療膽管癌的方法
HK1218506A1 (zh) 治療黑素瘤的方法
GB201401248D0 (en) Method of manufacture
ZA201506534B (en) Method of treating hair
EP2968273A4 (en) METHOD FOR THE TREATMENT OF MUSCLE DYSTROPHIES
HK1215164A1 (zh) 處理方法
HK1224230A1 (zh) 治療細胞內感染的方法
ZA201507475B (en) Method for the treatment of gas
IL241096B (en) Treatment methods
GB201305231D0 (en) Method of Manufacture
EP2961401A4 (en) METHOD FOR TREATING OTOTOXICITY
EP2958572A4 (en) TREATMENT OF HYPERHIDROSIS
GB201308466D0 (en) Improved process for treatment of minewater
PL3082860T3 (pl) Sposób leczenia ran
GB2518928B (en) Method of depilation
HK1204991A1 (en) Perm treatment method
EP2985265A4 (en) PROCESS FOR TREATING RESIDUAL WATER
ZA201601626B (en) Treatment of gases
PL3041506T3 (pl) Sposób leczenia
GB201322778D0 (en) Method of treatment
GB201314882D0 (en) Method of treatment
AU2013904712A0 (en) Method of Treatment
AU2013904170A0 (en) Method of treatment
GB201311291D0 (en) Method of manufacture
AU2013901359A0 (en) Methods of Treatment